BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced ...

BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ...

BRAINTREE, Mass., Nov. 20, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient ...

(RTTNews) - Haemonetics Corp. (HAE) on Thursday announced that it has received 510(k) clearance from the FDA for the new TEG 6s Hemostasis analyzer system Global Hemostasis-HN assay cartridge. This ...

In recent months, Haemonetics has reported a recovery in its Hospital division, supported by broader adoption of its FDA-approved NexSys PCS system with Persona Technology and the completed transition ...

Growth was driven by plasma and Blood Management Technologies — plasma rose about 20% organically (ex‑CSL) and BMT grew 8% — while Interventional Technologies declined ~12% due mainly to ...

Haemonetics Corporation HAE, a global medical technology company, has introduced a limited market release of VASCADE MVP XL mid-bore venous closure device. The device comes with innovative collapsible ...

Haemonetics Balances Robust Growth with Interventional Headwinds in Upbeat Earnings Call Haemonetics’ latest earnings call struck a broadly positive tone, with management emphasizing strong and ...